As of Jun 16, 2026, the UNH stock has a P/E ratio of 30.7. The calculation is based on the latest EPS of $13.28 and the stock price of $407.65 per share. An increase of 60% has been observed in the PE ratio compared to its average of 19.1 of the past four quarters.
The mean historical PE ratio of Unitedhealth Group over the last ten years is 22.29. The current 30.7 price-to-earnings ratio is 38% more than the historical average. Analyzing the last ten years, UNH's PE ratio reached its highest point in the Sep 2024 quarter at 37.65, with a price of $584.68 and an EPS of $15.53. The Jun 2025 quarter saw the lowest point at 13.42, with a price of $311.97 and an EPS of $23.25.
Maximum annual increase: 48.14% in 2024
Maximum annual decrease: -23.13% in 2025
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2025 | 24.86 | -23.13% | $330.11 | $13.28 |
| 2024 | 32.34 | 48.14% | $505.86 | $15.64 |
| 2023 | 21.83 | -11.58% | $526.47 | $24.12 |
| 2022 | 24.69 | -9.86% | $530.18 | $21.47 |
| 2021 | 27.39 | 26.75% | $502.14 | $18.33 |
| 2020 | 21.61 | 6.98% | $350.68 | $16.23 |
| 2019 | 20.2 | 0.95% | $293.98 | $14.55 |
| 2018 | 20.01 | -0.6% | $249.12 | $12.45 |
| 2017 | 20.13 | -7.32% | $220.46 | $10.95 |
| 2016 | 21.72 | 12.6% | $160.04 | $7.37 |
| 2015 | 19.29 | 10.29% | $117.64 | $6.1 |
| 2014 | 17.49 | 29.84% | $101.09 | $5.78 |
| 2013 | 13.47 | 33.63% | $75.3 | $5.59 |
| 2012 | 10.08 | -4.36% | $54.24 | $5.38 |
| 2011 | 10.54 | 20.87% | $50.68 | $4.81 |
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Mar 2026 | 20.38 | -18.02% | $270.59 | $13.28 |
| Dec 2025 | 24.86 | 38.81% | $330.11 | $13.28 |
| Sep 2025 | 17.91 | 33.46% | $345.3 | $19.28 |
| Jun 2025 | 13.42 | -38.33% | $311.97 | $23.25 |
| Mar 2025 | 21.76 | -32.71% | $523.75 | $24.07 |
| Dec 2024 | 32.34 | -14.1% | $505.86 | $15.64 |
| Sep 2024 | 37.65 | 12.96% | $584.68 | $15.53 |
| Jun 2024 | 33.33 | 11.77% | $509.26 | $15.28 |
| Mar 2024 | 29.82 | 36.6% | $494.7 | $16.59 |
| Dec 2023 | 21.83 | 0.92% | $526.47 | $24.12 |
| Sep 2023 | 21.63 | 1.84% | $504.19 | $23.31 |
| Jun 2023 | 21.24 | -0.47% | $480.64 | $22.63 |
| Mar 2023 | 21.34 | -13.57% | $472.59 | $22.15 |
| Dec 2022 | 24.69 | 1.23% | $530.18 | $21.47 |
| Sep 2022 | 24.39 | -7.82% | $505.04 | $20.71 |
The Historical Valuation Regime chart shows where the stock's current valuation sits relative to its own historical valuation range over the selected lookback period.
This is a history-relative tool, not a market-relative percentile. It does not compare the stock to other companies. Instead, it compares each historical valuation reading to the stock's own past readings.
The threshold lines are calculated them from the stock's real historical values using percentile interpolation. That is why some colored bands are narrow while others are wide: the band widths reflect how the stock actually traded through time.
| Historical percentile | Regime | Chart meaning |
|---|---|---|
| 0-10 | Historically Low | Deep cheap zone |
| >10-25 | Below Average | Cheap relative to history |
| >25-75 | Average | Within the normal historical range |
| >75-90 | Above Average | Expensive relative to history |
| >90-100 | Historically High | Extreme or stretched valuation |
| Chart element | What it tells you |
|---|---|
| Main line | The actual historical valuation values over time for the selected metric. |
| Dashed horizontal lines | The stock's computed P10, P25, Median, P75, and P90 thresholds for the selected period. |
| Colored bands | The historical valuation zones between those thresholds. |
| Metric boxes | Current ratio, historical median, current percentile, and current regime. |
| Timeline strip | A condensed regime history showing how the stock moved between cheap, fair, and expensive states across each observation. |
Current Percentile is the percentile rank of the latest valid historical observation within the selected lookback range.
Current Regime is assigned directly from the latest observation's percentile bucket using the fixed 10 / 25 / 75 / 90 cutoffs shown above.
This chart is most useful for answering a narrow question: Is this stock trading high, low, or normal relative to its own history? It works best alongside growth, profitability, and forward-looking business analysis, because a stock can deserve a higher or lower regime if its business quality has changed.
The current PE ratio of UNH is higher than the 3, 5 and 10-year averages.
With a price to earnings (P/E) of 30.7, UNH stands higher than the Healthcare sector average but lower than the industry average. Looking at the Healthcare sector average of 23.99, Unitedhealth Group's price to earnings (P/E) is 28% higher.
UNH's PE ratio is less than its peer stock HUM, but it is above CI's.
| Stock name | PE ratio | Market cap |
|---|---|---|
| CI Cigna Corp | 12.28 | $77.21B |
| UNH Unitedhealth Group Inc | 30.7 | $370.21B |
| HUM Humana Inc | 39.35 | $44.36B |
| CNC Centene Corp | N/A | $30.31B |
As of Jun 16, 2026, UNH stock has a price to earnings ratio of 30.7.
As an average over the last 3 years, UNH stock has a PE ratio of 24.68.
As an average over the last 5 years, UNH stock has a PE ratio of 24.9.
Over the last ten years, the Sep 2024 quarter recorded the highest quarterly PE ratio at 37.65.
UNH's current price to earnings ratio is 38% above its 10-year historical average.
You can calculate the P/E ratio by dividing the most recent stock price by the trailing twelve months earnings per share(EPS). As of today (Jun 16, 2026), Unitedhealth Group's share price is $407.65. The company's earnings per share for the trailing twelve months (TTM) ending Mar 2026 is $13.28. Therefore, Unitedhealth Group's price to earnings ratio for today is 30.7. PE RATIO(30.7) = STOCK PRICE($407.65) / TTM EPS($13.28)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.